Estradiol/Levonorgestrel Patch for Menopause
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate how two hormone-containing skin patches affect the skin of women experiencing menopause. Researchers seek to determine if one patch causes more skin irritation or allergic reactions than the other. Participants will wear the patches on different body parts to compare results. Women who are naturally or surgically postmenopausal, weigh 90 kg or less, and are generally healthy may qualify for this trial. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this new treatment.
What prior data suggests that these transdermal delivery systems are safe for skin use?
Research has shown that Estradiol/Levonorgestrel skin patches are generally easy to use and well-tolerated. These patches already help alleviate menopause symptoms like hot flashes. However, studies have identified some side effects. Common ones include skin reactions at the application site, vaginal bleeding, and breast pain. Other possible side effects are headaches and nausea.
The FDA has approved these patches for menopause symptoms, indicating their safety for that purpose. However, like any treatment, they carry risks. Serious but less common issues include stroke or blood clots. Discussing these risks with a healthcare provider is important before joining a trial.12345Why are researchers excited about this trial?
Unlike other treatments for menopause that typically involve oral or injectable hormone therapies, the Estradiol/Levonorgestrel Transdermal Delivery System (TDS) offers a unique patch-based approach. This transdermal system delivers hormones directly through the skin, which may help maintain stable hormone levels and reduce side effects often associated with pills. Researchers are excited about the potential for this patch to provide a more convenient and potentially safer alternative to traditional hormone replacement therapies, which often require daily dosing and can be harder on the digestive system. By focusing on a combination of estradiol and levonorgestrel, this method aims to effectively manage menopausal symptoms while offering a simpler, potentially more comfortable option for patients.
What evidence suggests that this trial's treatments could be effective for skin irritation and sensitization in menopause?
Studies have shown that the estradiol/levonorgestrel patch effectively treats menopausal symptoms like hot flashes and night sweats. The patch releases hormones through the skin, which helps reduce these symptoms. Research indicates that it significantly decreases the frequency and severity of hot flashes. Users have reported quick relief, making it a promising option for menopausal women. Additionally, the patch adheres well to the skin, ensuring consistent hormone delivery. Participants in this trial will apply the estradiol/levonorgestrel patch differently: one group will place half of the patch on the right buttock and the other half on the left, while the other group will do the reverse.12678
Are You a Good Fit for This Trial?
This trial is for healthy postmenopausal women. Participants should not have any skin conditions or allergies that could affect the study results, and must be able to safely use hormone patches.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Induction Period
Participants receive repeated applications of the test and comparator TDS to assess skin irritation
Rest Period
Participants have a rest period between the Induction and Challenge periods
Challenge Period
Evaluation of possible allergic or sensitization reactions to the TDS
Re-Challenge Period
Additional evaluation for participants who require further sensitization assessment
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Estradiol/Levonorgestrel Transdermal Delivery System (TDS)
Trial Overview
The study compares two hormone patches—Estradiol/Levonorgestrel TDS and Climara Pro TDS—to see how each affects the skin when applied repeatedly. Researchers will look at irritation, allergic reactions, and how well the patches stick.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Corium Innovations, Inc.
Lead Sponsor
Citations
Efficacy of a new 7-day transdermal sequential estradiol ...
Conclusions: The new 7-day transdermal sequential estradiol/levonorgestrel patch was well tolerated, providing rapid and effective relief of menopausal symptoms ...
Efficacy of a new 7-day transdermal sequential estradiol/ ...
Results: The sequential use of a 7-day estradiol patch and a 7-day estradiol/levonorgestrel patch was superior to placebo in reducing menopausal symptoms, and ...
3.
mayoclinic.org
mayoclinic.org/drugs-supplements/estradiol-and-levonorgestrel-transdermal-route/description/drg-20112971Estradiol and levonorgestrel (transdermal route)
Estradiol and levonorgestrel combination skin patch is used treat moderate to severe symptoms of menopause (eg, feelings of warmth in the face, neck, and ...
4.
dovepress.com
dovepress.com/clinical-efficacy-of-estradiol-transdermal-system-in-the-treatment-of--peer-reviewed-fulltext-article-RRTDClinical efficacy of estradiol transdermal system in the ...
The frequency of hot flashes was reduced in up to 84% of cases using doses as low as 0.025 mg/day. There were no significant differences between ...
About Climara Pro® Treatment for Menopausal VMS
The most common adverse reactions (≥5%) with Climara Pro, are: application site reaction, vaginal bleeding, breast pain, upper respiratory infection, back pain ...
6.
dailymed.nlm.nih.gov
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eabc0fb3-da2a-482f-83a7-99b1e823a150CLIMARA PRO- estradiol and levonorgestrel patch - DailyMed
These are some of the warning signs of serious side effects: Breast lumps Unusual vaginal bleeding Dizziness and faintness Changes in speech Severe headaches ...
3387147 This label may not be the latest approved by FDA ...
The Women's Health Initiative (WHI) estrogen plus progestin substudy reported increased risks of stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), ...
Estradiol/levonorgestrel Safety Alerts, Recalls & Warnings
The following FDA safety notices may be specifically about estradiol/levonorgestrel or relate to a group or class of drugs which include ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.